Business Unit of Bayer Corporation to Represent Molnlycke to Nation's Largest
Hospital and Purchasing Alliances
PHILADELPHIA, Pa., and WEST HAVEN, Conn., Feb. 7 /PRNewswire/ -- Bayer
Health Care Partners (BHCP) and Molnlycke Health Care announced today that
they have entered into a five-year account management and consulting
agreement. According to the agreement, BHCP will represent Molnlycke's wound
care product portfolio to major U.S. group purchasing alliances, investor-
owned hospitals, integrated delivery systems, and long-term care providers.
BHCP, formed in 1997, already represents the Bayer Consumer Care, Bayer
Diagnostics and Bayer Pharmaceutical divisions, as well as its alliance
partners, AGFA Medical Imaging and Schein Pharmaceutical.
Molnlycke Health Care (pronounced: MUN licka) provides products featuring
Safetac(TM) technology. This proprietary technology addresses modern concerns
in wound management, notably the pain and trauma associated with dressing
changes, which disrupt the wound healing process.
"We are proud to enter into this strategic alliance with Bayer Health Care
Partners, a recognized leader and one of the country's pre-eminent Health Care
System sales and marketing service providers," said Bertrand Hughes, President
of Molnlycke Health Care US. Gerald Rosenberg, Chairman of Bayer Health Care
Partners, said, "This agreement underscores the commitment Bayer has to the
market and indicates the type of success we bring with BHCP."
Bob Simmons, President of Healthcare Alliance, Inc., a Chicago-based
health care consulting firm, hailed the agreement. "This is exactly the right
fit for both of these organizations. Molnlycke gains the access and expertise
of the Bayer Health Care Partners' organization, while Bayer enjoys an even
larger business base to represent in the market," he said.
Molnlycke Health Care
With almost 150 years of experience in developing clinical products,
Molnlycke Health Care is a leading supplier of surgical and wound management
products. Established in Sweden in 1849, the company has been supplying a wide
range of innovative, high-quality products to the medical community in North
America since 1979. Visit Molnlycke on the web at: Molnlyckehc.com.
Bayer Health Care Partners (BHCP)
With headquarters in West Haven, Conn., Bayer Health Care Partners
represents the health care businesses of Bayer Corporation in strategic
alliances and partnerships with key integrated health care coalitions. Bayer
Corporation is a research-based company with major businesses in health care
and life sciences and chemicals. The company had 1998 sales of $8.1 billion
and employs more than 23,000 people. Bayer Corporation is investing $15
billion in capital expenditures and research and development from 1995 through
the year 2004. 1999 capital investment and R&D expenditures are projected to
total $1.6 billion. Bayer Corporation, with headquarters in Pittsburgh, is a
member of the worldwide Bayer Group, a $31 billion international life
sciences, polymers and specialty chemicals group based in Leverkusen, Germany.
Visit the company on the Web at: BayerUS.com.
SOURCE Bayer Corporation
 back to top
Related links:
http://www.bayerus.com
Company News On-Call:
http://www.prnewswire.com/comp/092575.html or fax,
800-758-5804, ext. 092575
CONTACT:
George Couto of Bayer Corporation,
203-812-6612 or george.couto.b@bayer.com, or Keith Wright of
Molnlycke Health Care, 800-328-9043 or usdkewr@hq.Molnlycke.se
|
